IP Library Granted Patent US 9,717,580
Granted Patent B2
US 9,717,580 · App. 11/755,422 · Granted Aug 1, 2017

Pelvic floor implant system and method of assembly

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,717,580
App. No.
11/755,422
Granted
Aug 1, 2017
Kind
B2
Abstract

Surgical articles, implants and components suitable creating composite slings are described. Novel procedures for assembling and utilizing composite slings are also detailed.

Claims (25)

1. A surgical method for treating a pelvic floor disorder, comprising:

providing a sling having first and second ends to define a sling length, an intermediate portion adapted to support the urethra or the bladder neck, a translucent sheath covering at least a portion of the first end and the second end, and a continuous tensioning suture having a suture length adapted to contiguously extend from the first end, to the intermediate portion and to the second end to extend substantially along the entire longitudinal length of the sling, with the continuous tensioning suture interlaced with the sling, including interlaced through a plurality of mesh filaments substantially at a midpoint juncture of the longitudinal length of the sling and the suture length of the continuous tensioning suture, to provide an undulation along the longitudinal length of the sling such that an end of the suture extends out from the sheath at the second end of the sling, and the sheath includes one or more position markings;

providing a delivery device having a distal portion adapted for releasable attachment to the first end or second end of the sling;

attaching the distal portion of the delivery device to the first end of the sling;

delivering the first end of the sling to a therapeutically effective location in the pelvic region of a patient;

fixing the first end of the sling into the tissue of the patient;

detaching the delivery device from the first end of the sling;

attaching the distal portion of the delivery device to the second end of the sling;

delivering the second end of the sling to a therapeutically effective location in the pelvic region of the patient, the location being generally contralateral to the fixated location of the first end of the sling;

fixing the second end of the sling into the tissue of the patient;

removing the sheath; and

clamping across a width of the sling with a clamp tool such that a length of the tensioning suture and the width of the sling are secured in the clamp tool, the clamp tool including a slot adapted to guide a blade for cutting suture.

2. The method of claim 1 , wherein providing the sling includes providing the sling constructed of a porous mesh material.

3. The method of claim 1 , wherein providing the continuous tensioning suture includes providing the continuous tensioning suture generally midway between the longitudinal edges of the sling.

4. The method of claim 1 , wherein providing the sling includes providing a generally elongate sling.

5. The method of claim 1 , wherein providing the sling includes providing the sling having a y-shaped portion at least at one of the first or second ends.

6. The method of claim 1 , further including creating a single vaginal incision to facilitate introduction of the distal portion of the delivery device and the sling.

7. The method of claim 1 , further including creating a single vaginal incision, and at least one skin incision to facilitate introduction of at least the distal portion of the delivery device.

8. The method of claim 1 , further including fixing at least one of the first or second ends to the obturator foramen of the patient.

9. The method of claim 1 , further including fixing at least one of the first or second ends in the retropubic space of the patient.

10. The method of claim 1 , wherein at least one of the first and second ends includes an anchor.

11. The method of claim 1 , wherein the first and second ends include an anchor.

12. The method of claim 1 , wherein the continuous tensioning suture is affixed to the first end of the sling via a weld.

13. The method of claim 1 , wherein the continuous tensioning suture is affixed to the first end of the sling via a knot.

14. The method of claim 1 , wherein the continuous tensioning suture is affixed to the first end of the sling via an adhesive.

Assignments (17)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: ANDERSON, KIMBERLY A; LUND, ROBERT E; BOUCHIER, MARK S; STURZL, FRANCIS D, III; GOHMAN, JAMES A; BACHMAN, TIMOTHY A
To: AMS RESEARCH CORPORATION
Reel/Frame 035684/0402 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →